A comparative analysis of medically released men and women from the Canadian Armed Forces
Abstract: Introduction: Musculoskeletal (MSK) injuries and mental health (MH) disorders are the leading causes of medical attrition in the Canadian Armed Forces (CAF). Historically, medical attrition rates have been higher for women than men. In order to better understand the medical release trends of men and women, a descriptive analysis of the medical reasons for release was undertaken. Methods: Administrative data sources within the Department of National Defence were used to identify medically released personnel together with their primary medical diagnosis and demographic characteristics, including sex, age, and rank. The analysis included 5,180 Regular Force personnel medically released between April 1, 2014 and March 31, 2017. Results: While overall trends in the reasons for medical release were sometimes similar for men and women, statistically significant differences between the medical release reasons of men and women were found in several of the sub-groups considered. These sub-groups included non-commissioned members (NCMs), officers, Air personnel, and members who had not deployed in the 10 years prior to their release, as well as personnel in the earlier and later stages of their career. Discussion: An increased understanding of the differences between medically released men and women is important for the development of future injury and illness prevention strategies, which have the primary objective of improving the health and operational readiness of serving members, as well as a secondary objective of lowering medical attrition rates to improve overall retention in the CAF.
Abstract: Objective: The present study is a retrospective quasi-experimental study to evaluate the effectiveness of the Warrior PATHH (WP) program at improving posttraumatic growth (PTG) outcomes and reducing PTSD symptoms compared to a waitlist control among a sample of Veterans. Method: Participants (n = 164) were U.S. military Veterans with a history of trauma. Participants were either undergoing the Warrior PATHH program or a waitlist. Primary outcome measures were administered at baseline and at 90-day follow-up and consisted of the Posttraumatic Growth Inventory – Expanded (PTGI-X) and the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5). Secondary outcome measures assessed psychosocial functioning and included measures of depression and anxiety symptoms, sleep, wellbeing, and social support. Results: Significant differences were observed between groups on the PTGI-X (F(1, 205) = 23.667, p < .001, partial η2 = 0.103), and the PCL-5 (F(1, 205) = 262.460, p < .001, partial η2 = 0.561) with the WP group showing significant positive psychological change following a traumatic event as measured by the PTGI-X and decreased PTSD symptoms as measured by the PCL-5 compared to those in the waitlist condition. Those in the treatment arm also demonstrated gains to psychosocial functioning. Conclusions: Consistent with previous research, participants in the Warrior PATHH program exhibited significant increases in PTG outcomes, decreased PTSD symptoms, and broad improvements to psychosocial functioning. These findings suggest it is an effective training program to foster PTG outcomes among Veterans. This study is unique as it is the first to compare the effects of WP programming with a sample of waitlisted Veterans.